Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity

Cancer Immunity

Volumn 8, Issue , 2008, Pages

  Ishida, Toshiaki ^a   Obata, Yuichi ^b   Ohara, Nobuya ^a   Matsushita, Hirokazu ^a   Sato, Shuichiro ^a   Uenaka, Akiko ^a   Saika, Takashi ^a   Miyamura, Takako ^a   Chayama, Kosuke ^a   Nakamura, Yurika ^c   Wada, Hisashi ^c   Yamashita, Toshiharu ^d   Morishima, Tsuneo ^a   Old, Lloyd J ^e   Nakayama, Eiichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b RIKEN BIORESOURCE CENTER   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Gag; HERV K; Human; Prostate cancer; SEREX; Tumor antigen

Indexed keywords

AUTOANTIGEN; GAG PROTEIN; MESSENGER RNA; RECOMBINANT PROTEIN; TUMOR ANTIGEN; ANTISERUM; MONOCLONAL ANTIBODY; NGO PR 54 PROTEIN, HUMAN; NGO-PR-54 PROTEIN, HUMAN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CANCER PATIENT; CANCER SCREENING; CELL LINE; CELL SURFACE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN ENDOGENOUS RETROVIRUS; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; LEUKEMIA; MELANOMA CELL; MOLECULAR CLONING; MOLECULAR WEIGHT; OVARY CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; SEROLOGICAL RECOMBINANT CDNA EXPRESSION; SERUM; TUMOR GENE; WESTERN BLOTTING; AGED; ANIMAL; BAGG ALBINO MOUSE; CELL STRAIN COS1; CERCOPITHECUS; ENDOGENOUS RETROVIRUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MALE; MELANOMA; METABOLISM; MOLECULAR GENETICS; MOUSE; OVARY TUMOR; PROSTATE; PROSTATE TUMOR;

AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; ENDOGENOUS RETROVIRUSES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE PRODUCTS, GAG; HUMANS; IMMUNE SERA; LEUKEMIA; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROSTATE; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 56449110842     PISSN: None     EISSN: 14249634     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995; 92: 11810-11813. (PMID: 8524854)
2. Chen YT. Identification of human tumor antigens by serological expression cloning: an online review on SEREX. Cancer Immun 2004. URL: http://www.cancerimmunity.org/SEREX/
3. Jäger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A. Simul-taneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998; 187: 265-270. (PMID: 9432985)
4. Gnjatic S, Atanackovic D, Jäger E, Matsuo M, Selvakumar A, Altorki NK, Maki RG, Dupont B, Ritter G, Chen YT, Knuth A, Old LJ. Sur-vey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proc Natl Acad Sci USA 2003; 100: 8862-8867. (PMID: 12853579)
5. Gnjatic S, Nishikawa H, Jungbluth AA, Güre AO, Ritter G, Jäger E, Knuth A, Chen YT, Old LJ. NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res 2006; 95: 1-30. (PMID: 16860654)
6. Fisk B, Blevins TL, Wharton JT, Ioannides CG. Identification of an immunodominant peptide of HER-2/neu protooncogene recog-nized by ovarian tumor-specific cytotoxic T lymphocyte lines. J Exp Med 1995; 181: 2109-2117. (PMID: 7539040)
7. Jäger D, Karbach J, Pauligk C, Seil I, Frei C, Chen YT, Old LJ, Knuth A, Jäger E. Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes. Cancer Immun 2005; 5: 11. URL: http:// www.cancerimmunity.org/ v5p11/051014.htm
8. Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV. Digital expression profiles of human endogenous retroviral families in nor-mal and cancerous tissues. Cancer Immun 2004; 4: 2. URL: http:// www.cancerimmunity.org/v4p2/040102.htm
9. Löwer R, Löwer J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 1996; 93: 5177-5184. (PMID: 8643549)
10. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Nay-lor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rog-ers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dun-ham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Rich-ardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Wein-stock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blöcker H, Hornischer K, Nordsiek G, Agar-wala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Her-mjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mul-der N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ ; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921. (PMID: 11237011)
11. Tristem M. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol 2000; 74: 3715- 3730. (PMID: 10729147)
12. Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci USA 2004; 101 Suppl 2: 14572-14579. (PMID: 15310846)
13. Griffiths DJ. Endogenous retroviruses in the human genome sequence. Genome Biol 2001; 2: reviews1017.1-1017.5. (PMID: 11423012)
14. Ono M. Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retro-virus genes. J Virol 1986; 58: 937-944. (PMID: 3009897)
15. Löwer R, Boller K, Hasenmaier B, Korbmacher C, Müller-Lantzsch N, Löwer J, Kurth R. Identification of human endogenous retrovi-ruses with complex mRNA expression and particle formation. Proc Natl Acad Sci USA 1993; 90: 4480-4484. (PMID: 8506289)
16. Tönjes RR, Löwer R, Boller K, Denner J, Hasenmaier B, Kirsch H, König H, Korbmacher C, Limbach C, Lugert R, Phelps RC, Scherer J, Thelen K, Löwer J, Kurth R. HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13 Suppl 1: S261-S267. (PMID: 8797733)
17. Blond JL, Beseme F, Duret L, Bouton O, Bedin F, Perron H, Man-drand B, Mallet F. Molecular characterization and placental expres-sion of HERV-W, a new human endogenous retrovirus family. J Virol 1999; 73: 1175-1185. (PMID: 9882319)
18. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 1997; 94: 7583-7588. (PMID: 9207135)
19. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005; 15: 179-211. (PMID: 15782388)
20. Bieda K, Hoffmann A, Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J Gen Virol 2001; 82: 591-596. (PMID: 11172100)
21. Wang-Johanning F, Frost AR, Jian B, Azerou R, Lu DW, Chen DT, Johanning GL. Detecting the expression of human endogenous ret-rovirus E envelope transcripts in human prostate adenocarcinoma. Cancer 2003; 98: 187-197. (PMID: 12833471)
22. Leib-Mösch C, Brack-Werner R, Werner T, Bachmann M, Faff O, Erfle V, Hehlmann R. Endogenous retroviral elements in human DNA. Cancer Res 1990; 50: 5636S-5642S. (PMID: 2167160)
23. Lee YN, Bieniasz PD. Reconstitution of an infectious human endog-enous retrovirus. PLoS Pathog 2007; 3: e10. (PMID: 17257061)
24. Sauter M, Schommer S, Kremmer E, Remberger K, Dölken G, Lemm I, Buck M, Best B, Neumann-Haefelin D, Müller-Lantzsch N. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol 1995; 69: 414-421. (PMID: 7983737)
25. Löwer R, Tönjes RR, Korbmacher C, Kurth R, Löwer J. Identifica-tion of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol 1995; 69: 141-149. (PMID: 7983704)
26. Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, Cullen BR. An ancient family of human endogenous retroviruses encodes a func-tional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci USA 1999; 96: 13404-13408. (PMID: 10557333)
27. Büscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 2005; 65: 4172-4180. (PMID: 15899808)
28. Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBu-glio AF, Shaw DR, Strong TV. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clin Can-cer Res 2001; 7: 1553-1560. (PMID: 11410490)
29. Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, Chen DT, Lu DW, Barnhart KF, Johanning GL. Expression of mul-tiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer 2006; 120: 81-90. (PMID: 17013901)
30. Wang-Johanning F, Frost AR, Jian B, Azerou R, Lu DW, Chen DT, Johanning GL. Detecting the expression of human endogenous ret-rovirus E envelope transcripts in human prostate adenocarcinoma. Cancer 2003; 98: 187-197. (PMID: 12833471)
31. Wentzensen N, Coy JF, Knaebel HP, Linnebacher M, Wilz B, Gebert J, von Knebel Doeberitz M. Expression of an endogenous retroviral sequence from the HERV-H group in gastrointestinal cancers. Int J Cancer 2007; 121: 1417-1423. (PMID: 17546591)
32. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Sci-ence 1985; 230: 1132-1139. (PMID: 2999974)
33. Seil I, Frei C, Sültmann H, Knauer SK, Engels K, Jäger E, Zatloukal K, Pfreundschuh M, Knuth A, Tseng-Chen Y, Jungbluth AA, Stauber RH, Jäger D. The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer. Int J Cancer 2007; 120: 2635-2642. (PMID: 17330232)
34. Boller K, König H, Sauter M, Mueller-Lantzsch N, Löwer R, Löwer J, Kurth R. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retro-virus HTDV. Virology 1993; 196: 349-353. (PMID: 8356806)
35. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B, Yu J, Wang L, Montie JE, Rubin MA, Pienta KJ, Roulston D, Shah RB, Varambally S, Mehra R, Chinnaiyan AM. Distinct classes of chromosomal rear-rangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007; 448: 595-599. (PMID: 17671502)
36. Sauter M, Roemer K, Best B, Afting M, Schommer S, Seitz G, Hart-mann M, Mueller-Lantzsch N. Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. Cancer Res 1996; 56: 4362-4365. (PMID: 8813125)
37. Denner J, Phelps RC, Löwer J, Löwer R, Kurth R. Expression of the human endogenous retrovirus HERV-K in tumor and normal tis-sues and antibody response of pregnant women, tumor and AIDS patients against HERV-K Gag and Env peptides. AIDS Res Hum Ret-roviruses 1995; 11: 103.
38. Kleiman A, Senyuta N, Tryakin A, Sauter M, Karseladze A, Tjulan-din S, Gurtsevitch V, Mueller-Lantzsch N. HERV-K(HML-2) GAG/ ENV antibodies as indicator for therapy effect in patients with germ cell tumors. Int J Cancer 2004; 110: 459-461. (PMID: 15095315)
39. Schiavetti F, Thonnard J, Colau D, Boon T, Coulie PG. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res 2002; 62: 5510- 5516. (PMID: 12359761)
40. Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, McCoy JP, Hanada K, Mena O, Kurlander R, Tawab A, Srinivasan R, Lundqvist A, Malinzak E, Geller N, Lerman MI, Childs RW. Regres-sion of human kidney cancer following allogeneic stem cell trans-plantation is associated with recognition of an HERV-E antigen by T cells. J Clin Invest 2008; 118: 1099-1109. (PMID: 18292810)
41. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987; 7: 379-387. (PMID: 3031469)
42. Köhler G, Howe SC, Milstein C. Fusion between immunoglobulin- secreting and nonsecreting myeloma cell lines. Eur J Immunol 1976; 6: 292-295. (PMID: 825374)
43. Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1981; 23: 175-182. (PMID: 6260373)
44. Takaki T, Hiraki A, Uenaka A, Gomi S, Itoh K, Udono H, Shibuya A, Tsuji T, Sekiguchi S, Nakayama E. Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes. Int J Oncol 1998; 12: 1103-1109. (PMID: 9538136)
45. Niiya M, Niiya K, Kiguchi T, Shibakura M, Asaumi N, Shinagawa K, Ishimaru F, Kiura K, Ikeda K, Ueoka H, Tanimoto M. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells. Cancer Chemother Pharmacol 2003; 52: 391-398. (PMID: 12908082)
46. Shimono M, Uenaka A, Noguchi Y, Sato S, Okumura H, Nakagawa K, Kiura K, Tanimoto M, Nakayama E. Identification of DR9- restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells. Int J Oncol 2007; 30: 835-840. (PMID: 17332921)
47. Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, Mori S, Yokoi K, Horio Y, Shimokata K, Sekido Y, Hida T. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci 2006; 97: 387-394. (PMID: 16630136)
48. Ono T, Sato S, Kimura N, Tanaka M, Shibuya A, Old LJ, Nakayama E. Serological analysis of BALB/c methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen. Int J Cancer 2000; 88: 845-851. (PMID: 11093803)